• Denali Therapeutics (NASDAQ:DNLI) Earns Outperform Rating from Analysts at Robert W. Baird

    来源: Buzz FX / 07 1月 2025 07:26:15   America/Chicago


    Denali Therapeutics (NASDAQ:DNLI) Earns Outperform Rating from Analysts at Robert W. Baird Written by MarketBeat January 7, 2025 Share Link copied to clipboard. Stock analysts at Robert W. Baird initiated coverage on shares of Denali Therap
    Read more...
分享